We have a pipeline of novel, fast-follow PCCs (preclinical-candidate-compounds) for the therapies of metabolic and endocrine disorders.
|
PCC Pipelines |
|||
|
Development Programs |
Indication |
Drug Target |
Status |
|
CT175 |
Obesity, diabetes, MASH and others |
GIPR/GLP-1R agonist |
Pre-IND |
|
CT173 |
Obesity, diabetes, MASH and others |
GCGR/GLP-1R agonist |
Pre-IND |
|
CT178 |
Obesity, diabetes, MASH and others |
GCGR/GIPR/GLP-1R agonist |
Pre-IND |
Company address: Room N203, Building A5, No. 199 Mufu East Road, Gulou District, Nanjing City, Jiangsu Province, China
Contact information:
Mrs Tian (Business Manager) +86 15715144736 njzh_txg@chihealbio.com.cn
Mr Shi (Business Manager) +86 13770315946 njzh_swx@chihealbio.com.cn
